Idiopathic inflammatory demyelinating diseases (IIDDs) can present as focal brain lesions that may be clinically and radiographically indistinguishable from high grade primary tumours or other space occupying lesions such as abscess or metastasis.1,2 These tumefactive or pseudotumoural lesions may have a monophasic, self-limited course, but can also correspond to the first manifestation or appears during a typical relapsing form of multiple sclerosis (MS). On computed tomography (CT) or magnetic resonance (MR) imaging, these lesions usually present as large (